Insmed Accounts payable and other current liabilities decreased by 137.5% to -$33.88M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.9%, from -$61.49M to -$33.88M. Over 2 years (FY 2023 to FY 2025), Accounts payable and other current liabilities shows an upward trend with a 157.0% CAGR.
An increase suggests the company is effectively utilizing supplier credit to preserve cash, while a decrease indicates faster payment cycles.
Reflects the net change in obligations to suppliers and other accrued expenses that have been incurred but not yet paid....
A standard working capital metric used to evaluate cash management strategies across all sectors.
other_increase_decrease_in_accounts_payable_and_accrued__ecb401| Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.36M | -$16.92M | -$8.84M | $9.07M | -$6.78M | $21.71M | -$32.35M | $35.08M | $725.00K | $41.13M | -$61.49M | $25.66M | $45.56M | $90.35M | -$33.88M |
| QoQ Change | — | -226.6% | +47.8% | +202.5% | -174.8% | +420.3% | -249.0% | +208.5% | -97.9% | >999% | -249.5% | +141.7% | +77.6% | +98.3% | -137.5% |
| YoY Change | — | — | -166.2% | +153.6% | — | — | -265.9% | +287.0% | +110.7% | +89.5% | -90.1% | -26.9% | >999% | +119.7% | +44.9% |